Annual Operating Expenses:
$795.39M+$189.09M(+31.19%)Summary
- As of today, BBIO annual total operating expenses is $795.39 million, with the most recent change of +$189.09 million (+31.19%) on December 31, 2024.
- During the last 3 years, BBIO annual operating expenses has risen by +$152.16 million (+23.66%).
- BBIO annual operating expenses is now at all-time high.
Performance
BBIO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Expenses:
$249.80M+$10.03M(+4.18%)Summary
- As of today, BBIO quarterly total operating expenses is $249.80 million, with the most recent change of +$10.03 million (+4.18%) on September 30, 2025.
- Over the past year, BBIO quarterly operating expenses has increased by +$61.77 million (+32.85%).
- BBIO quarterly operating expenses is now at all-time high.
Performance
BBIO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BBIO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +31.2% | +32.9% |
| 3Y3 Years | +23.7% | +103.7% |
| 5Y5 Years | +161.4% | +95.0% |
BBIO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +46.6% | at high | +105.3% |
| 5Y | 5-Year | at high | +161.4% | at high | +105.3% |
| All-Time | All-Time | at high | +1713.6% | at high | +619.0% |
BBIO Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $249.80M(+4.2%) |
| Jun 2025 | - | $239.77M(+10.4%) |
| Mar 2025 | - | $217.11M(-3.2%) |
| Dec 2024 | $795.39M(+31.2%) | $224.37M(+19.3%) |
| Sep 2024 | - | $188.03M(+8.7%) |
| Jun 2024 | - | $172.94M(-15.8%) |
| Mar 2024 | - | $205.48M(+16.4%) |
| Dec 2023 | $606.30M(+11.7%) | $176.52M(+10.6%) |
| Sep 2023 | - | $159.57M(+12.2%) |
| Jun 2023 | - | $142.27M(+15.7%) |
| Mar 2023 | - | $122.94M(+1.0%) |
| Dec 2022 | $542.65M(-15.6%) | $121.70M(-0.8%) |
| Sep 2022 | - | $122.65M(-14.7%) |
| Jun 2022 | - | $143.84M(-4.3%) |
| Mar 2022 | - | $150.38M(-15.6%) |
| Dec 2021 | $643.23M | $178.27M(+18.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $150.39M(+3.5%) |
| Jun 2021 | - | $145.24M(-13.3%) |
| Mar 2021 | - | $167.50M(+31.4%) |
| Dec 2020 | $482.73M(+58.6%) | $127.49M(-0.5%) |
| Sep 2020 | - | $128.07M(+2.8%) |
| Jun 2020 | - | $124.57M(+21.5%) |
| Mar 2020 | - | $102.49M(+30.3%) |
| Dec 2019 | $304.30M(+65.7%) | $78.64M(-0.2%) |
| Sep 2019 | - | $78.77M(+13.6%) |
| Jun 2019 | - | $69.32M(+8.9%) |
| Mar 2019 | - | $63.64M(+53.8%) |
| Dec 2018 | $183.66M(+318.8%) | - |
| Sep 2018 | - | $41.38M(+19.1%) |
| Jun 2018 | - | $34.74M(-16.9%) |
| Mar 2018 | - | $41.81M |
| Dec 2017 | $43.86M | - |
FAQ
- What is BridgeBio Pharma, Inc. annual total operating expenses?
- What is the all-time high annual operating expenses for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. annual operating expenses year-on-year change?
- What is BridgeBio Pharma, Inc. quarterly total operating expenses?
- What is the all-time high quarterly operating expenses for BridgeBio Pharma, Inc.?
- What is BridgeBio Pharma, Inc. quarterly operating expenses year-on-year change?
What is BridgeBio Pharma, Inc. annual total operating expenses?
The current annual operating expenses of BBIO is $795.39M
What is the all-time high annual operating expenses for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high annual total operating expenses is $795.39M
What is BridgeBio Pharma, Inc. annual operating expenses year-on-year change?
Over the past year, BBIO annual total operating expenses has changed by +$189.09M (+31.19%)
What is BridgeBio Pharma, Inc. quarterly total operating expenses?
The current quarterly operating expenses of BBIO is $249.80M
What is the all-time high quarterly operating expenses for BridgeBio Pharma, Inc.?
BridgeBio Pharma, Inc. all-time high quarterly total operating expenses is $249.80M
What is BridgeBio Pharma, Inc. quarterly operating expenses year-on-year change?
Over the past year, BBIO quarterly total operating expenses has changed by +$61.77M (+32.85%)